Open AccessErythema Multiforme Major following SARS‐CoV‐2 vaccine
Author(s) -
Saibene Alberto Maria,
Alliata Andrea,
Cozzi Anna Teresa,
Ottavi Alice,
Spagnolini Sofia,
Pipolo Carlotta,
Maccari Alberto,
Felisati Giovanni
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4947
Subject(s) - erythema multiforme , medicine , erythema , dermatology , covid-19 , intensive care medicine , pathology , disease , infectious disease (medical specialty)
Erythema multiforme major, an immune‐mediated skin reaction to infections or medications with oral involvement, should be taken into account as a potential side effect of several vaccines, including SARS‐CoV‐2. Correct patient history collection allows prompt recognition and subsequent successful medical management with oral corticosteroids.